Cargando…
Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairment
INTRODUCTION: The safety of predicting conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) dementia using apolipoprotein E (APOE) genotyping is unknown. METHODS: We randomized 114 individuals with MCI to receive estimates of 3‐year risk of conversion to AD dementia infor...
Autores principales: | Christensen, Kurt D., Karlawish, Jason, Roberts, J. Scott, Uhlmann, Wendy R., Harkins, Kristin, Wood, Elisabeth M., Obisesan, Thomas O., Le, Lan Q., Cupples, L. Adrienne, Zoltick, Emilie S., Johnson, Megan S., Bradbury, Margaret K., Waterston, Leo B., Chen, Clara A., Feldman, Sara, Perry, Denise L., Green, Robert C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087414/ https://www.ncbi.nlm.nih.gov/pubmed/32211507 http://dx.doi.org/10.1002/trc2.12002 |
Ejemplares similares
-
A Randomized Controlled Trial of Disclosing Genetic Risk Information for Alzheimer’s Disease via Telephone
por: Christensen, Kurt D., et al.
Publicado: (2017) -
Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants
por: Harkins, Kristin, et al.
Publicado: (2015) -
Gender Differences in How the American Public Reacts to a Person With Mild-Stage Dementia
por: Stites, Shana, et al.
Publicado: (2020) -
The goldilocks conundrum: Disclosing discrimination risks in informed consent
por: Prince, Anya E. R., et al.
Publicado: (2022) -
To disclose, or not to disclose? Context matters
por: Rahimzadeh, Vasiliki, et al.
Publicado: (2015)